27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
A wave of Wall Street analysts are initiating coverage of the cannabis space for the first time, and Stifel is the latest firm to weigh in on Canopy Growth Corp (NYSE:CGC).
The Analyst
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Stifel's W. Andrew Carter initiated coverage of Canopy with a Buy rating and a C$64 ($47.77 USD) price target.
The Thesis
Carter said Canopy is leading the cannabis pack when it comes to expanding its large-scale national infrastructure in Canada.
“We believe Canopy Growth represents the best investable opportunity for capitalizing on the growth of the global cannabis category with Canopy sporting definitive leadership in the Canadian cannabis market, multiple avenues for attacking the U.S. market with Canopy positioned for success no matter the timeline for U.S. federal legalization, and advantaged positions for capitalizing on global medical-use opportunities,” Carter wrote in a note.
Need more cannabis news? Check out all of our coverage here.
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
He said the $4 billion investment by Constellation Brands, Inc. (NYSE:STZ) last year has helped fuel Canopy’s aggressive growth strategy by funding potential acquisitions. Constellation also has the resources to help Canopy continue to build up its national supply chain and develop new products, Carter wrote.
In particular, Carter said Canopy’s partnership with Constellation could differentiate the company when it comes to the cannabis-infused beverage market.
Carter said Canopy has a huge advantage in the U.S. market in a potential federal legalization scenario thanks to its option to acquire Acreage Holdings. Canopy is not financially committed to the deal unless the U.S. legalizes cannabis, which protects investors financial interests.
Price Action
Canopy shares traded about 1 higher to $41.22 on Thursday.
Related Links:
Analyst Likes Tilray In The Long Run, But Says Stock Is Overvalued Right Now
Analyst: Cronos And Altria Make A Powerful Team
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.